SEZI — Senzime AB (publ) Share Price
0.000.00%
Last trade - 00:00- SEK713.45m
- SEK573.90m
- SEK35.75m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.9 | ||
| Price to Tang. Book | 4.81 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 19.95 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -33.54% | ||
| Return on Equity | -42.09% | ||
| Operating Margin | -384.18% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 6.71 | 9.34 | 10.98 | 14.03 | 35.75 | 80 | 199 | 61.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Senzime publ AB is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Directors
- Philip Siberg CHM (44)
- Pia Renaudin CEO (54)
- Erik Bergman CFO (62)
- Christopher Estes CEX (52)
- Johanna Tulkki COO (51)
- Anders Jacobson CTO (54)
- Anders Selin VPR (59)
- Catrin Molund VBD (51)
- Johanna Faris OTH (46)
- Sorin Brull DRC (65)
- Adam Dahlberg DRC (48)
- Lennart Kalen DRC (72)
- Eva Walde DRC (58)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- January 26th, 1999
- Public Since
- June 18th, 2008
- No. of Employees
- 50
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 119,705,678
- Address
- Ulls Vag 41, UPPSALA, 756 51
- Web
- https://senzime.com/
- Phone
- +46 18515640
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for SEZI
Senzime AB (publ) Annual Shareholders Meeting
Senzime AB (publ) Annual Shareholders Meeting
Q2 2024 Senzime AB (publ) Earnings Release
Similar to SEZI
Acarix AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Aegirbio AB
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Senzime AB (publ) share price?
As of Today at 19:19 UTC, shares in Senzime AB (publ) are trading at SEK5.96. This share price information is delayed by 15 minutes.
How has the Senzime AB (publ) share price performed this year?
Shares in Senzime AB (publ) last closed at SEK5.96 and the price had moved by +13.74% over the past 365 days. In terms of relative price strength the Senzime AB (publ) share price has outperformed the FTSE Global All Cap Index by +6.78% over the past year.
What are the analyst and broker recommendations for Senzime AB (publ)?
There is no consensus recommendation for this security.
What is the Senzime AB (publ) dividend yield?
Senzime AB (publ) does not currently pay a dividend.
Does Senzime AB (publ) pay a dividend?
Senzime AB (publ) does not currently pay a dividend.
When does Senzime AB (publ) next pay dividends?
Senzime AB (publ) does not currently pay a dividend.
How do I buy Senzime AB (publ) shares?
To buy shares in Senzime AB (publ) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Senzime AB (publ)?
As of the previous close price of SEK5.96, shares in Senzime AB (publ) had a market capitalisation of SEK713.45m.
Where are Senzime AB (publ) shares listed?
Here are the trading details for Senzime AB (publ):
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: SEZI
What kind of share is Senzime AB (publ)?
Based on an overall assessment of its quality, value and momentum Senzime AB (publ) is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Senzime AB (publ) share price forecast for 2024?
The analyst consensus target price for shares in Senzime AB (publ) is SEK13.50. That is 126.51% above the last closing price of SEK5.96.
Analysts covering Senzime AB (publ) currently have a consensus Earnings Per Share (EPS) forecast of -SEK0.89 for the next financial year.
What is the trend in the Senzime AB (publ) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Senzime AB (publ). Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -18.99%.
As of the last closing price of SEK5.96, shares in Senzime AB (publ) were trading -6.54% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Senzime AB (publ) PE Ratio?
The Senzime AB (publ) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK5.96.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Senzime AB (publ)?
Senzime AB (publ)'s management team is headed by:
- Philip Siberg - CHM
- Pia Renaudin - CEO
- Erik Bergman - CFO
- Christopher Estes - CEX
- Johanna Tulkki - COO
- Anders Jacobson - CTO
- Anders Selin - VPR
- Catrin Molund - VBD
- Johanna Faris - OTH
- Sorin Brull - DRC
- Adam Dahlberg - DRC
- Lennart Kalen - DRC
- Eva Walde - DRC